Cite
Mahapatra L, Andruska N, Mao C, et al. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol. 2017;10(5):818-827doi: 10.1016/j.tranon.2017.07.008.
Mahapatra, L., Andruska, N., Mao, C., Le, J., & Shapiro, D. J. (2017). A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Translational oncology, 10(5), 818-827. https://doi.org/10.1016/j.tranon.2017.07.008
Mahapatra, Lily, et al. "A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation." Translational oncology vol. 10,5 (2017): 818-827. doi: https://doi.org/10.1016/j.tranon.2017.07.008
Mahapatra L, Andruska N, Mao C, Le J, Shapiro DJ. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol. 2017 Oct;10(5):818-827. doi: 10.1016/j.tranon.2017.07.008. Epub 2017 Aug 29. PMID: 28846937; PMCID: PMC5576976.
Copy
Download .nbib